Navigation Links
Treatment of Premature Babies, Opossums Could Help

Reserarchers have discovered striking similarities between the immune systems of humans and opossums, the famous Australian marsupial .

It could also lead to breakthroughs in the understanding and treatment of facial tumours afflicting the Tasmanian Devils, carnivorous marsupials now found only in the Australian island state of Tasmania.

A US research team compiled the full set of genetic information of the South American opossum, the first time scientists had done so for a marsupial.

Dr Kathy Belov of the University of Sydney was among 11 Australians taking part in an international study led by the leading genomic research centre, the Broad Institute in Boston.

Dr Belov was involved in the painstaking task of comparing the genetic information revealed about the opossum's immune system with that of humans by using highly complex algorithms, or mathematical formulae, on computers.

'We actually found the human and the opossum immune systems are very similar and that was a real a surprise to us,' Ms Belov said.

'People have thought for a long time the marsupial immune system was primitive and not as good as the human immune system, whereas we've actually shown they are actually on par.'

Dr Belov said the discovery meant opossums would make good models for the study of human disease.

Opossums are born without an immune system, which develops as they hang off their mother's teats.

Not only does that make it easier for scientists to study them but a good understanding how the defenceless young survive in the presence of disease-producing organisms known as pathogens would have much wider benefits.

'We can transfer that information to humans where you have problems with premature babies coming down with infections,' Dr Belov said.

'We think that having this basic information about the genome will really help us to expand the field into these new areas. '

The researchers are also working to compile the genome sequence of other marsupials, such as the platypus and the tama wallaby, which will be Australia's first genome project.

Armed with just 'one or two' marsupial sequences, scientists expect to be able learn much more about the little understood scourge of the facial tumours afflicting Tasmanian Devils, Dr Belov said.

The sequences would give the experts the tools to measure the immune responses to the tumours, she said.

This would allow them to better compare animals which recover from the tumours and those that don't.

'That would certainly help us understand the tumour and hopefully come up with a cure in the long term,' Dr Belov said.

Similarly, the genome sequence could help tackle chlamydia in koalas, which is often triggered by the stress of loss of habitat, she said.

Chlamydia is a common sexually transmitted infection among humans, caused by the bacterium, Chlamydia trachomatis, which can damage a womans reproductive organs. Even though symptoms of chlamydia are usually mild or absent, serious complications that cause irreversible damage, including infertility, can occur 'silently' before a woman ever recognizes a problem. Chlamydia also can cause discharge from the penis of an infected man.


Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:

(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: